Supplementary Material for: Lenvatinib as second-line treatment after atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma –clinical results show importance of hepatic reserve function

  • Atsushi Hiraoka (Contributor)
  • Takashi Kumada (Contributor)
  • Toshifumi Tada (Contributor)
  • Masashi Hirooka (Contributor)
  • Kazuya Kariyama (Contributor)
  • Joji Tani (Contributor)
  • Masanori Atsukawa (Contributor)
  • Koichi Takaguchi (Contributor)
  • Ei Itobayashi (Contributor)
  • Shinya Fukunishi (Contributor)
  • Kunihiko Tsuji (Contributor)
  • Toru Ishikawa (Contributor)
  • Kazuto Tajiri (Contributor)
  • Hironori Ochi (Contributor)
  • Satoshi Yasuda (Contributor)
  • Hidenori Toyoda (Contributor)
  • Chikara Ogawa (Contributor)
  • Takashi Nishimura (Contributor)
  • Takeshi Hatanaka (Contributor)
  • Satoru Kakizaki (Contributor)
  • Noritomo Shimada (Contributor)
  • Kazuhito Kawata (Contributor)
  • Atsushi Naganuma (Contributor)
  • Hisashi Kosaka (Contributor)
  • Tomomitsu Matono (Contributor)
  • Hidekatsu Kuroda (Contributor)
  • Y. Yata (Contributor)
  • Hideko Ohama (Contributor)
  • Fujimasa Tada (Contributor)
  • Kazuhiro Nouso (Contributor)
  • Asahiro Morishita (Contributor)
  • Akemi Tsutsui (Contributor)
  • Takuya Nagano (Contributor)
  • Norio Itokawa (Contributor)
  • Tomomi Okubo (Contributor)
  • Taeang Arai (Contributor)
  • Keisuke Yokohama (Contributor)
  • Michitaka Imai (Contributor)
  • Yohei Koizumi (Contributor)
  • Shinichiro Nakamura (Contributor)
  • Hiroko Iijima (Contributor)
  • Masaki Kaibori (Contributor)
  • Yoichi Hiasa (Contributor)

Dataset

Filter
Article

Search results